Persistent Asset Partners »

Nektar Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $983k 17k 56.90

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
UnitedHealth (UNH)
Regeneron Pharmaceuticals (REGN)
CVS Caremark Corporation (CVS)
Nebius Group Shs Class A (NBIS)
Pdd Holdings Sponsored Ads (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Soleno Therapeutics (SLNO)
BioMarin Pharmaceutical (BMRN)
Labcorp Holdings Com Shs (LH)
Anthem (ELV)
Healthcare Services (HCSG)
Quest Diagnostics Incorporated (DGX)
Brightspring Health Svcs (BTSG)

View all positions for Persistent Asset Partners

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics